
Neovasc NVCN
Geschäftsbericht 2021
hinzugefügt 23.12.2023
Neovasc Betriebszyklus 2011-2026 | NVCN
Betriebszyklus Jährlich Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 130 | 95.3 | 58.4 | 63.8 | 73.8 | 83.4 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 130 | 58.4 | 84.1 |
Betriebszyklus anderer Aktien in der Medizinische Geräte
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | ||
|
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
339 | - | - | $ 3.31 B | ||
|
Acutus Medical
AFIB
|
853 | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M | ||
|
Cognyte Software Ltd.
CGNT
|
76.7 | $ 7.22 | - | $ 518 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
160 | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
299 | $ 3.91 | -1.69 % | $ 135 M | ||
|
Alphatec Holdings
ATEC
|
351 | $ 13.54 | -2.59 % | $ 1.94 B | ||
|
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
216 | - | - | $ 16.4 M | ||
|
Bio-Rad Laboratories
BIO
|
304 | $ 294.76 | -1.65 % | $ 8.32 B | ||
|
Bruker Corporation
BRKR
|
274 | - | 1.76 % | $ 6.31 K | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
CONMED Corporation
CNMD
|
278 | $ 42.22 | -1.31 % | $ 1.3 B | ||
|
Boston Scientific Corporation
BSX
|
184 | - | -0.69 % | $ 108 B | ||
|
Abbott Laboratories
ABT
|
183 | - | 0.72 % | $ 197 B | ||
|
Cutera
CUTR
|
462 | - | -10.19 % | $ 1.99 M | ||
|
Cardiovascular Systems
CSII
|
254 | - | 0.15 % | $ 844 M | ||
|
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
266 | $ 13.28 | -2.28 % | $ 359 M | ||
|
EDAP TMS S.A.
EDAP
|
163 | $ 5.0 | 8.7 % | $ 186 M | ||
|
Dynatronics Corporation
DYNT
|
133 | - | 14.99 % | $ 929 K | ||
|
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
InMode Ltd.
INMD
|
246 | $ 14.26 | -2.67 % | $ 1.13 B | ||
|
Eargo
EAR
|
156 | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
228 | - | - | $ 207 M | ||
|
Second Sight Medical Products
EYES
|
224 | - | -0.97 % | $ 54.4 M | ||
|
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
251 | $ 18.57 | -0.75 % | $ 122 M | ||
|
IRadimed Corporation
IRMD
|
308 | $ 103.26 | - | $ 1.31 B | ||
|
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | ||
|
Integer Holdings Corporation
ITGR
|
120 | $ 86.35 | - | $ 2.9 B | ||
|
Globus Medical
GMED
|
343 | $ 88.28 | -0.37 % | $ 12 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
265 | $ 11.05 | - | $ 851 M | ||
|
Pulmonx Corporation
LUNG
|
337 | $ 1.45 | -0.34 % | $ 56.7 M | ||
|
Establishment Labs Holdings
ESTA
|
634 | $ 72.06 | - | $ 2.03 B | ||
|
Medigus Ltd.
MDGS
|
411 | - | 10.28 % | $ 55.5 M | ||
|
IRIDEX Corporation
IRIX
|
170 | $ 1.43 | - | $ 23.1 M | ||
|
Invacare Corporation
IVC
|
289 | - | - | $ 24.7 M | ||
|
Cytosorbents Corporation
CTSO
|
175 | $ 0.62 | -7.09 % | $ 33.7 M |